Literature DB >> 22114613

Commentary: Anxiety Disorders and Perceptual Disturbances in Adolescents with 22q11.2 Deletion Syndrome Treated with SSRI: A Case Series.

Anne S Bassett1.   

Abstract

Entities:  

Year:  2011        PMID： 22114613      PMCID： PMC3222575     

Source DB:  PubMed          Journal:  J Can Acad Child Adolesc Psychiatry        ISSN： 1719-8429


× No keyword cloud information.
  7 in total

1.  Elevated prevalence of generalized anxiety disorder in adults with 22q11.2 deletion syndrome.

Authors:  Wai Lun Alan Fung; Rebecca McEvilly; Jessica Fong; Candice Silversides; Eva Chow; Anne Bassett
Journal:  Am J Psychiatry       Date:  2010-08       Impact factor: 18.112

2.  Practical guidelines for managing patients with 22q11.2 deletion syndrome.

Authors:  Anne S Bassett; Donna M McDonald-McGinn; Koen Devriendt; Maria Cristina Digilio; Paula Goldenberg; Alex Habel; Bruno Marino; Solveig Oskarsdottir; Nicole Philip; Kathleen Sullivan; Ann Swillen; Jacob Vorstman
Journal:  J Pediatr       Date:  2011-05-12       Impact factor: 4.406

Review 3.  Cognitive, behavioural and psychiatric phenotype in 22q11.2 deletion syndrome.

Authors:  Nicole Philip; Anne Bassett
Journal:  Behav Genet       Date:  2011-05-15       Impact factor: 2.805

4.  Association of schizophrenia in 22q11.2 deletion syndrome and gray matter volumetric deficits in the superior temporal gyrus.

Authors:  Eva W C Chow; Andrew Ho; Corie Wei; Eduard H J Voormolen; Adrian P Crawley; Anne S Bassett
Journal:  Am J Psychiatry       Date:  2011-03-01       Impact factor: 18.112

Review 5.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Authors:  David T Miller; Margaret P Adam; Swaroop Aradhya; Leslie G Biesecker; Arthur R Brothman; Nigel P Carter; Deanna M Church; John A Crolla; Evan E Eichler; Charles J Epstein; W Andrew Faucett; Lars Feuk; Jan M Friedman; Ada Hamosh; Laird Jackson; Erin B Kaminsky; Klaas Kok; Ian D Krantz; Robert M Kuhn; Charles Lee; James M Ostell; Carla Rosenberg; Stephen W Scherer; Nancy B Spinner; Dimitri J Stavropoulos; James H Tepperberg; Erik C Thorland; Joris R Vermeesch; Darrel J Waggoner; Michael S Watson; Christa Lese Martin; David H Ledbetter
Journal:  Am J Hum Genet       Date:  2010-05-14       Impact factor: 11.025

6.  The schizophrenia phenotype in 22q11 deletion syndrome.

Authors:  Anne S Bassett; Eva W C Chow; Philip AbdelMalik; Mirona Gheorghiu; Janice Husted; Rosanna Weksberg
Journal:  Am J Psychiatry       Date:  2003-09       Impact factor: 18.112

Review 7.  Schizophrenia and 22q11.2 deletion syndrome.

Authors:  Anne S Bassett; Eva W C Chow
Journal:  Curr Psychiatry Rep       Date:  2008-04       Impact factor: 5.285
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.